ArticleApplied microbiology and biotechnology2026
Whey protein isolate enhances the growth and probiotic features of Lacticaseibacillus rhamnosus GG.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lacticaseibacillus rhamnosus strain GG (LGG) is a broadly used probiotic with several unique features that help it provide beneficial effects to its host. Key among the probiotic features of LGG is the production of bioactive metabolites and secreted proteins such as p40 and p75. The ability of LGG to persist in the gastrointestinal tract depends primarily on its ability to adhere to the gut mucosa via the generation of adhesion pili. While LGG is already used as a probiotic, potential still exists for optimization of the metabolic state of LGG to further enhance its probiotic capacity. Here, we evaluated the ability of whey protein isolate to enhance the cell growth and probiotic effects of LGG. RNA sequencing and untargeted metabolomics revealed that WPI supplementation enhanced LGG growth and metabolic activity and increased the transcription of genes for the production of adhesion pili, key secreted proteins, and beneficial metabolites. These results indicate that whey protein is a viable supplement option for use with LGG and may help to boost the probiotic activity and growth of LGG within the gastrointestinal tract. KEY POINTS: • Whey protein isolate supplementation increases Lacticaseibacillus rhamnosus GG growth. • Transcription of genes for probiotic features is amplified by the addition of WPI. • Transcriptomics and metabolomics suggest the protein produces the beneficial effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.